Related to Breast Cancer Stage

Size: px
Start display at page:

Download "Related to Breast Cancer Stage"

Transcription

1 Breast Self-Examination and Medical Examination Related to Breast Cancer Stage RUBY T. SENIE, RN, MA, PAUL PETER ROSEN, MD, MARTIN L. LESSER, PHD, AND DAVID W. KINNE, MD Abstract: The frequency and type of breast examinations reported by 1,21 primary breast cancer patients was studied in relation to local stage of disease. No significant relationship was found between the reported frequency of breast self-examination (BSE) and stage of disease; however, annual medical examination was significantly associated with small tumor size (P <.01) and absence of axillary lymph node metastases (P <.001). Regardless of the frequency of any method of examination, the majority (0 per cent) of tumors were first detected by the patients. Among those who detected their lesion, a greater frequency of medical examination was associated with an earlier pathological stage of disease (P <.001). Patients who were examined more frequently by a physician appeared to be more sensitive to clincially significant breast abnormalities. These findings underscore the importance of examiner skill in the successful use of palpation to detect breast cancer. Instruction in BSE by a health professional during periodic examinations may provide the optimal opportunity for improved proficiency in self-examination. (Am J Public Health 191; 71:53-0.) Until a method of prevention is readily available, diagnosis and treatment of breast carcinoma at an early stage provide the greatest opportunity for long-term survival. Poorer prognosis has been repeatedly associated with increasing stage of disease. 1 2 During the past few years it has been reported that more patients have presented with smaller tumors.3 Factors which may have contributed to this trend include: the establishment of breast cancer screening centers; more frequent inclusion of breast evaluation by physicians during routine physical examinations; and greater patient awareness of breast diseases through publicity by the media. Breast self-examination (BSE) has been encouraged by some clinicians as a valuable aid in early detection especially among those considered at increased risk.4 Others have questioned the ability of patients to detect small tumors in view of the difficulties physicians have experienced when evaluating large breasts or those composed of dense tissue.5 The purpose of this study is to describe the regularity of breast examinations reported by breast cancer patients. We have chosen especially to explore the relationships of physician evaluation and patient self-examination to local stage of disease. From the Memorial Sloan Kettering Cancer Center. Address reprint requests to Dr. Paul Peter Rosen, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY Ms. Senie, formerly a research associate with the Department of Pathology, is currently a doctoral student in epidemiology at Yale University. Dr. Lesser is with the Biostatistics Laboratory, and Dr. Kinne is Chief of the Breast Service, Department of Surgery. This paper, submitted to the Journal September, 190, was revised and accepted for publication January 13, 191. Editor's Note: See also related editorial, p. 572, this issue. Methods and Materials Interviews were conducted with 1,21 breast cancer patients consecutively admitted at Memorial Sloan-Kettering Cancer Center between October 197 and June 197, 97 per cent of the women with primary carcinoma admitted during the 22-month period. The frequency of breast selfexamination (BSE), physician examination, mammography and method of detection were among the items investigated as part of a general study of pathologic and epidemiologic aspects of breast cancer.7 Pathological review conducted by one of the authors provided data pertaining to the extent of axillary nodal involvement. The gross size of the primary tumor was measured at the time of diagnosis at Memorial Hospital and has been excluded for those patients referred for treatment after diagnosis elsewhere. The statistical significance of associations was tested using methods of chi square applied to contingency tables. The y (gamma) statistic was computed to assess the strength of association between ordinal variables or between an ordinal and dichotomous variable. Analysis of variance was used to determine the significance of differences between means for the variables tumor size and age at diagnosis. Mantel-Haenszel techniques were applied to stratified data. Results The Study Population At diagnosis the 1,21 women ranged in age from 21 to 95 years with a mean of 5 (SD = 12). A greater percentage were age 0 or older (39 per cent) than under 45 years (19 per AJPH June 191, Vol. 71, No. 53

2 SENIE, ET AL. TABLE 1-The Frequency of Self Examination in Relation to Selected Variables (0 Patients) (4 Patients) (37 Patients) Monthly Occasionally Never Age Group at N % N % N % Diagnosis' <45 years Menstrual Status2 Pre Peri Post Education Level3 <High Schobl HS or Vocational College or higher Family History4 Present Absent Prior Benign Breast Disease Biopsy Proven Clinical Only None Hypertension History No History Marital Status Never Married Currently Married Previously Married 'P<.001, y =.19 2p <.005, y =.5 3P <.04, y = -.0 4P <.02 SP <.001 p <.003 'P <.02, y = -.15 cent). Using previously described criteria for menstrual status,9 27 per cent were pre-, 22 per cent peri-, and 51 per cent postmenopausal. The racial distribution was 91 per cent White, 7 per cent Black, and 2 per cent Hispanic or Oriental. More women were Jewish (42 per cent) than Catholic (3 per cent), or Protestant (1 per cent), other or no religious preference ( per cent). Among the 23 per cent of the population who were foreign born, the majority (9 per cent) were from Europe. Approximately 3 per cent of the women had completed high school (some with vocational training) and 40 per cent indicated college or graduate school education. Most patients were or had been married (92 per cent) and a majority gave a history of at least one full pregnancy (79 per cent). A familial history of breast carcinoma in one or more relatives was reported by 32 per cent of the women. Prior surgically treated benign disease was indicated by per cent and an additional 24 per cent gave a history of having had a clinically diagnosed benign condition. Medical care was reported by 30 per cent for hypertension, 19 per cent for thyroid disorders, and 7 per cent for diabetes. More than 43 per cent indicated use of steroid hormones at some point following puberty for one of the following: contraception, relief of menstrual or menopausal symptoms, prevention of miscarriage or lactation. 54 Relative weight categories (under, optimum, and over) were computed using the Metropolitan Life Insurance Table of Desirable Weights for Women. The full range of weight for small through large frame was considered optimum for each height. The optimum range varied from 10 (±+14) pounds for women 4'" to 15 (±+ 1) pounds for those 5' 1'. Invasive carcinomas were detected in 91 per cent of the patients; infiltrating duct carcinoma was the mnost frequent histologic type (9 per cent). Eleven per cent of the tumors were larger than 4 cm while 40 per cent were less than 2 cm. Axillary lymph node metastases were identified in 41 per cent of the 1,10 women who had an axillary dissection and internal mammary lymph nodes contained carcinoma in 30 per cent of the 10 cases treated by extended radical mastectomy. More than 52 per cent of the tumors were located in the upper outer quadrant of the breast. The left breast was affected in 5 per cent of the cases. Mean tumor size among the 1,011 measured lesions was 2. cm. Previous treatment for contralateral breast carcinoma was reported by 2 patients (7 per cent) and 102 ( per cent) were diagnosed with simultaneous bilateral disease. Self-Examination Patients were asked if they practiced BSE. Those who gave an affirmative response were questioned further con- AJPH June 191, Vol. 71, No.

3 BREAST EXAMINATION AND CANCER STAGE TABLE 2-Medical Examination with Breast Evaluation In Past 10 Years In Relation to Selected Factors Age Groups' < Menstrual Status2 Pre Peri Post Education Level3 <High School HS or Vocational College or higher Family History4 History No History Prior Benign5 Breast Disease Biopsy Proven Clinical Only None Prior Breast4 Cancer History No History Thyroid Disease History No History Hypertension5 History No History Marital Status7 Never Married Currently Married Previously Married Religion5 Jewish Protestant Catholic Other Hormone Usage5 Ever Never Relative Weight Under Optimum Over Frequency of Breast Self Examination5 Monthly Occasionally Never N (72 Patients) (2 Patients) (13 Patients) Yearly Less Frequent Never N N 'P <.001, y =.24 2p <.001, y =.2 3P <.001, y = -. 4P <.01 5P <.001 p <.03 7P <.001, y =.1 Bp <.003 ceming the frequency and regularity of BSE during the three years prior to entry into the study. Three frequency groups were established: at least monthly, occasional (every two or three months), and never, with reported frequencies of 29 per cent, 40 per cent, and 29 per cent respectively. No attempt was made to evaluate the technique or skill of the patients who gave a history of breast self-examination. AJPH June 191, Vol. 71, No. Selected variables were analyzed for the three frequency groups of self-examination (Table 1). A pattern of decreasing frequency of BSE with increasing age at diagnosis was observed. The mean age at diagnosis of women who reported monthly BSE was 53 years (SD = 12), five years younger than those who never performed self-examination, with a mean for occasional practicers of 5 years (SD = 12). 55

4 SENIE, ET AL. TABLE 3-Frequency of Medical Examination Related to Tumor Size and Axillary Nodal Status' Tumor Size2 Nodal Status2 Examination Frequency < 2 cm. 2 cm Negative Positive N % N % N % N % Yearly Less Frequent Never Includes 1,011 measured tumors and 100 microscopic lesions; 1,10 with axillary lymph node evaluations. 2p <.001 (y =.32, tumor size, -y =.21, nodal status). 3No significant difference from this resuft was found when patients with axillary metastases were subclassified by number of involved nodes (1-3 vs. 4 or more). Analysis of variance of the mean age of the patients in the three groups indicated statistically significant differences (P <.001). Monthly BSE was reported more frequently by patients with the following factors: presently married, higher education level, premenopausal status, family history of breast cancer, prior benign breast disease (either clinically diagnosed or surgically treated), and more frequent medical examination of the breasts. No significant association was found between the frequency of BSE and the following: religion, hormone usage, and relative weight. Mean tumor sizes were compared by analysis of variance. No significant differences from the overall mean of 2. cm (SD = 1.7) were observed in relation to the frequency of BSE. After stratifying the data by family history of breast cancer, history of benign breast disease, education level, and relative weight, no significant association between tumor size and frequency of self-examination was identified. No correlation was detected between the presence of axillary lymph nodes metastases and regularity of BSE within the total population nor within the stratified categories. Medical Examination of Breasts Yearly examinations were reported by 0 per cent, while 29 per cent were seen less often, and 11 per cent had not had an examination by a physician during the ten years prior to diagnosis. The frequency of medical examination in relation to selected variables is displayed in Table 2. The mean age of those who had not seen a physician during the ten years prior to diagnosis was 2 years (SD = 13), eight years more than those reporting annual or more frequent checks. Patients with intermediate examination schedules had a mean age of 57 years (SD + 12). Analysis of variance of age at diagnosis for the three frequency groups indicated significant differences (P <.001) between the means. Older women, although less likely to have annual breast examinations, reported frequent blood pressure and cardiac evaluations. There was no association between a history of hypertension and the frequency of physicians' evaluation of the breasts. Tumor size and axillary lymph node status at the time of diagnosis were significantly correlated with the frequency of medical examination (Table 3). A more favorable stage of disease was associated with more frequent physician examination. Among those who had yearly medical examinations, the mean size was 2.3 cm (SD = 1.4), significantly smaller than the 3.4 cm (SD = 2.2) mean tumor size of those who had not been examined within ten years of diagnosis (P <.001). Those with infrequent medical evaluations were noted to have an intermediate mean size of 2. cm (SD = 1.). Relationship of BSE and Medical Examination Frequency As noted above, a significant association was observed between the frequency of BSE and medical examination of TABLE 4-Size of Tumor in Relation to the Frequency of Examinations* Breast Examination < 2 cm 2 2 cm Totals BSE/Medical N % N % (a) Monthly/yearly (b) Occasionally or never/yearly (c) Monthly/less frequently or never (d) Occasionally or never/ less frequently or never Total Table P <.001 (a) vs (b) NS, Odds Ratio 1.2 (c) vs (d) NS, Odds Ratio 1.0 (a) vs (c) P <.005, Odds Ratio 2.2 (b) vs (d) P <.001, Odds Ratio 1. (a + b) vs (c + d) P <.001,y =., Odds Ratio 1.9 'Includes 1,011 measured tumors and 100 microscopic lesions. 5 AJPH June 191, Vol. 71, No.

5 TABLE 5-Axillary Nodal Status in Relation to Frequency of Examinations* Nodal Status BREAST EXAMINATION AND CANCER STAGE Breast Examinations Negative Positive Totals N % N % (a) Monthly/yearly (b) Occasionally or never/yearly (c) Monthly/less frequently (d) Occasionally or never/ less frequently or never Total Table P <.003 (a) vs (b) NS, Odds Ratio 1.3 (c) vs (d) NS, Odds Ratio 1.0 (a) vs (c) P <.03, Odds Ratio 1. (b) vs (d) P <.03, Odds Ratio 1.4 (a + b) vs (c + d) P <.001, y =.21, Odds Ratio 1.5 *Includes 1,10 patients with axillary lymph node evaluations. the breasts. To investigate this further, patients were grouped with regard to both types of examination. Four subsets were established: a) Monthly BSE/yearly medical b) Occasional or never BSE/yearly medical c) Monthly BSE/less frequent or no medical d) Occasional or never BSE/less frequent or no medical The relationships of these four patterns of examination with tumor size and nodal status are presented in Tables 4 and 5. Although the differences in overall distribution in each table were significant, further analysis revealed that subsets (a) and (b) did not differ appreciably from each other. Subsets (c) and (d) presented similar relationships. By comparing subset (a) with (c) the influence of the frequency of medical examination among the 3 reporting monthly BSE was evaluated. Women reporting annual medical examinations were found to have a significantly higher proportion of tumors less than 2 cm than those with less frequent or no medical evaluations (P <.005). The odds ratio of 2.2 confirms the strength of the association. A similar although less significant finding (P <.03) was observed in relation to the proportion of patients with no axillary nodal metastases. Comparison of combined subsets (a + b) and (c + d) revealed significant differences with respect to tumor size and nodal status; the odds ratios of 1.9 and 1.5 indicate the association with frequency of medical examination. The combined subsets were stratified by menstrual status (Table ) and analyzed by the Mantel Haenszel technique. Controlling for menopausal group, a significant association was noted when tumor size was analyzed by the examination frequency subsets. The analysis of nodal status by examination frequency also revealed a significantly different pattern among the stratified subsets. Method of Detection Among the 957 patients who were asked how the tumor TABLE -Tumor Size and Axillary Nodal Status in Relation to Examination Schedule Stratified by Menstrual Status Tumor Size Nodal Status Menstrual Status < 2cm 2cm Negative Positive Premenopausal(1,2) N % N % N % N % (a + b) (c + d) Perimenopausal(3,4) (a + b) (c + d) Postmenopausal(5,) (a + b) (c + d) (Tumor Size, Nodal Status) 'p <.01, -y =.37, Odds Ratio 2.2 2p <.01, -y =.39, Odds Ratio 2.3 3NS, y =.19, Odds Ratio 1.5 4NS, y =.1, Odds Ratio 1.4 5P <.001, y =.34, Odds Ratio 2.0 NS, y =.15, Odds Ratio 1.4 AJPH June 191, Vol. 71, No. 57

6 SENIE, ET AL. TABLE 7-Method of Detection in Relation to Tumor Size and Axillary Nodal Status' Tumor Size2 Nodal Status3 Detected by < 2cm 2 2cm Negative Positive N % N % N % N % Patient Physician Mammography ' Includes 70 with measurable tumors and 929 with axillary lymph node evaluations among the 957 patients with known method of detection. 2Tumor Size Total Table P <.0001 Patient vs Physician P < Nodal Status Total Table P <.0001 Patient vs Physician P <.001 was first detected,* a majority reported self-detection (0 per cent). Symptoms described by a small proportion included: pain or injury ( per cent); nipple discharge (3 per cent); or change is size or shape of the breast (1 per cent). The frequency of self-detection did not differ significantly by histologic type in the group of cases with invasive duct, lobular, or medullary lesions. Among the 42 patients with a history of previously diagnosed benign or malignant breast disease, the proportion of tumors self-detected was smaller than among those without prior breast conditions (74 per cent and 4 per cent respectively, P <.001). The method of detection was analyzed to separate the contribution of physician examination and mammography (Table 7). In 15 per cent of the cases, the lesion was initially found during a routine breast examination by a physician and in 5 per cent by mammography. Measured tumor size and the frequency of axillary lymph node metastases differed significantly by method of detection (P <.0001). After exclusion of patients with lesions detected by mammography, significant differences were noted in stage of disease between physician and patient detected cases. This observation is further supported by the finding of a significant difference (P <.01) in mean tumor size between tumors detected by physician palpation (2.1 cm SD = 1.4) and by the patient (2.7 cm SD = 1.7). Among the women who detected their carcinoma, size distribution was not significantly related to the frequency of BSE. However, a significantly greater proportion of lesions smaller than 2 cm was observed when women who detected their own carcinoma reported annual medical examinations. Relative weight was significantly associated with tumor size among those reporting self detection (P <.001). Women who were 20 or more pounds over their optimum range were more likely to have lesions of 2 cm or larger (2 per cent) than were those patients at ideal weight or less than 20 pounds in excess (5 per cent). Among those detected during a routine medical examination, weight was not a significant factor. *This question was added to the study four months after the first patients were accessioned. 5 Discussion Some clinicians consider emphasis on routine monthly self examination unduly frightening while others have recommended the practice and have provided careful instruction in BSE especially for those considered at high risk. Two recently published studiesl'0 1 described an association between more frequent BSE and less advanced stages of breast carcinoma. This observation was not confirmed in a study by Smith, et al,12 or by the data we have reported. We found no significant differences in mean tumor size or axillary lymph node status in relation to the frequency of breast self examination. Conceivably, this lack of agreement could be the result of differences in study design. In one report, interviews were conducted by several investigators using patients from seven institutions.'0 There was a 71 per cent participation rate. Those who refused interview tended to be older and more often widowed. These two factors were observed to be significantly related to frequency of BSE in our study and may have been a source of bias. Another study contained data recorded by an unspecified number of physicians prior to treatmentll as part of their clinical evaluation. Certainly, lack of uniform data ascertainment would be a serious concern. In addition, information was available for only 73 per cent of potential cases. We have minimized these types of selection bias in the present study. Personal interviews were conducted primarily by one nurse with 97 per cent of all consecutively diagnosed and treated breast cancer patients in one institution during a 22-month period. Demographic data such as age at diagnosis, menstrual status, and education level have been found to be significantly related to the frequency of health care practices. These may be reflected in geographic and institutional differences between populations studied. Therefore, an appreciation of the distribution of these variables among different populations is necessary before one can compare them with respect to methods of breast examination. By separating the frequency of BSE into three categories (monthly, occasionally, and less frequent or never), we were able to evaluate tumor size and nodal status in relation AJPH June 191, Vol. 71, No.

7 BREAST EXAMINATION AND CANCER STAGE to these patterns. Other reports have not considered the frequency of self examinationl' or have joined those with a monthly pattern and those performing BSE occasionally.12 Foster, et al,11 who categorized their patients into the same three frequency groups as in our study, observed a positive effect of BSE when patients were analyzed by clinical stage. Those in Stages 0, I and II were compared to patients clinically staged in III or IV. Although measured tumor size was found to differ significantly when women who reported ever performing BSE were compared to those who never practiced self-examination, the presence of pathologically determined axillary metastases did not show a significant associaton to BSE practice. Our findings agree with those of other studies in which decreasing frequency of BSE was associated with increasing age."1 A positive relationship between higher education levels and greater regularity of health care practices has also been noted."' 13 However, Greenwald, et al,10 using multivariate analysis did not detect any interaction between factors which we found significantly related to frequency of BSE and medical examination including: menstrual status, marital status, age, and education level. As in several other reviews,1012 we did not assess the skill of women reporting monthly or occasional BSE. Howe has reported that the abilities of women claiming to perform BSE varied considerably with only a small proportion competent enough to detect lumps in a simulated model.'4 The majority of the present study population may also have lacked skill and this would have obscured the beneficial effects for those who practiced BSE proficiently. Other possibly confounding factors that could not be controlled and may have affected our results include the degree of honesty and recall ability of those interviewed. Thiessen found that breast size and tissue characteristics could substantially limit the effectiveness of self exami- nation. These features, difficult to quantify for accurate comparisons, were not evaluated for the patients in this study. However, the significant relationship that we observed between relative body weight and tumor size among those reporting self detection suggests that breast size has an effect on tumor detection by patients. Our data indicate that BSE as currently practiced by the women in this study should not substitute for evaluation by a physician. We believe this is primarily the result of differences in the skill of the examiners. It is possible that careful instruction and routine practice would sufficiently improve BSE proficiency to enable a woman to be as effective in examining her own breasts as a trained professional. Although we found that monthly BSE practiced by our study population did not provide a diagnostic advantage over examination by physicians, comparing BSE frequency among women who sought annual medical examinations suggests some positive effects of BSE in this group. No similar influence was detected when BSE frequency was analyzed in women who did not seek annual medical examinations. It is reasonable to speculate that the observed benefit among those reporting annual physician evaluation and monthly BSE results from the interest of the individual women in their health care practices and the influence of breast examination procedures practiced by their physicians. Others have observed that the greatest degree of efficiency and compliance on a monthly basis has been achieved following personal instruction by a physician or a nurse. 15- Our data should not be taken to imply that routine medical examination of the breasts need necessarily be performed by a physician. Several authors have noted that, within a screening situation, nurse clinicians can be highly successful in identifying significant, palpable lesions.'' 19 Hall, et al,20 were able to demonstrate that training with standardized models improved the ability of a group of nonprofessional volunteers to detect breast lumps. There is evidence to suggest that careful instruction in the performance of BSE with periodic breast examination by a skilled professional other than a physician may provide an important contribution to the clinical diagnosis of breast cancer. 21, 22 REFERENCES 1. Berg JW, Robbins GF: Factors influencing short and long term survival of breast cancer patients. Surg. Gynecol Obstet 19;122: Say CC, Donegan WL: Invasive carcinoma of the breast: prognostic significance of tumor size and axillary nodes. Cancer 1974;34: Fox MS: On the diagnosis and treatment of breast cancer. JAMA 1979;241: Haagensen CD: Diseases of the Breast, 2nd Ed. Philadelphia: W.B. Saunders, 1971: Moore F: Breast self-examination. N Eng J Med 197;299: Thiessen EV: Breast self-examination in proper prospective. Cancer 1971;2: Senie RT, Rosen PP, Lesser ML, et al: Epidemiology of breast carcinoma II: Factors related to the predominance of left sided disease. Cancer 190;4:1-1%.. Goodman LA, Kruskal WH: Measures of association for cross classification. J AM Stat Assoc 1954;49: Rosen PP, Senie RT, et al: Epidemiology of breast carcinoma: Age, menstrual status, and exogenous hormone usage in patients with lobular carcinoma in situ. Surgery 1979;5: Greenwald P, Nasca PC, Lawrence CE, et al: Estimated effect of breast self-examination and routine physician examination on breast cancer mortality. N Eng J Med 197;299: Foster RS, Lang SP, Costanza MC, et al: Breast self-examination practices and breast cancer stage. N Eng J Med 197;299: Smith EM, Francis AM, Polissar L: The effect of breast selfexam practices and physician examinations in extent of disease at diagnosis. Prev Med 190;9: Moss AJ, Wilder MH: Use of selected medical procedures associated with preventive care, United States, Vital and health statistics: Series 10, Data from the National Health Survey; No. 110 (DHEW pub. No. (HRA) , 1977, Washington, D.C. 14. Howe H: Breast self-examination proficiency: the basic element of BSE efficacy. Public Health Rep. March, April issue McCusker J, Morrow GR: Factors related to the use of cancer early detection techniques. Prev Med 190;9: Rose MR: Survey reveals women's attitudes to breast selfexamination. NZ Nursing J 197;71: Strax P: Strategy (motivation) for detection of early breast cancer. Cancer 190;4: Moskowitz M: Clinical examination of the breasts by nonphysicians. A viable screening option? Cancer 1979;44:1-4. AJPH June 191, Vol. 71, No. 59

8 SENIE, ET AL. 19. George WD, Sellwood RA, Asbury D, Hartley G: Role of nonmedical staff in screening for breast cancer. Br Med J 190;2: Hall DC, Adams CK, Stein GH, et al: Improved detection of human breast lesions following experimental training. Cancer 190;4: Gastrin G: Programme to encourage self-examination for breast cancer. Br Med J 190;2: Mahoney U, Bird BL, Cooke GM: Annual clinical examination. N Eng J Med 1979;301:5-. ACKNOWLEDGMENT This study was supported by Contract NO1-CB3997, Breast Cancer Task Force, National Cancer Institute. I Forum Scheduled on Hospital's Role in Care for Elderly I A "Forum on Health Care for the Elderly: The Hospital's Role" will be held in Chicago, June , 191, hosted by the Hospital Research and Educational Trust (the Trust) and the American Hospital Association (AHA) under the sponsorship of the Administration on Aging of the US Department of Health and Human Services. The invitational forum, organized by the AHA/Trust Office on Aging and Long-Term Care, will bring together hospital and health care leaders to address the issues facing hospitals as a result of demographic trends, the changing nature of the hospital patient, and the resulting changing role of the hospital. Sessions will address the characteristics of the elderly patient, reorientation of the hospital's internal resources, reorientation of the hospital's relationship to other health care providers, manpower implications, and the consequences for financing of health care. An advisory panel was appointed to commission and to review papers from leading authorities for each of the sessions. The AHA and the Trust jointly established the Office on Aging and Long-Term Care to identify and foster effective responses from hospitals to the health needs of the growing elderly population. The Office is working toward a number of objectives including: establishing an information clearinghouse; publishing and disseminating information; conducting conferences and demonstration and research projects; and establishing liaisons with public policy and aging groups to encourage joint efforts promoting the effective care for the elderly. For further information about the June forum, contact the AHA/Trust Office on Aging and Long-Term Care, the Hospital Research and Educational Trust, 40 North Lake Shore Drive, Chicago, IL 01 1; phone 2/ AJPH June 191, Vol. 71, No.

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.

More information

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for

More information

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal

More information

OBJECTIVES By the end of this segment, the community participant will be able to:

OBJECTIVES By the end of this segment, the community participant will be able to: Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening The American Cancer Society and Congregational Health Ministry Team October Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry

More information

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D. Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are

More information

How To Decide If You Should Get A Mammogram

How To Decide If You Should Get A Mammogram American Medical Women s Association Position Paper on Principals of Breast Cancer Screening Breast cancer affects one woman in eight in the United States and is the most common cancer diagnosed in women

More information

Breast Cancer. Presentation by Dr Mafunga

Breast Cancer. Presentation by Dr Mafunga Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over

More information

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics In Situ Breast Cancer in Wisconsin INTRODUCTION This bulletin provides information

More information

Florida Breast Health Specialists Breast Cancer Information and Facts

Florida Breast Health Specialists Breast Cancer Information and Facts Definition Breast cancer is a cancer that starts in the tissues of the breast. There are two main types of breast cancer: Ductal carcinoma starts in the tubes (ducts) that move milk from the breast to

More information

Medicare Part B. Mammograms - Updated Billing Guide for Screening and Diagnostic Tests

Medicare Part B. Mammograms - Updated Billing Guide for Screening and Diagnostic Tests Mammograms - Updated Billing Guide for Screening and Diagnostic Tests This article from Medicare B News Issue 223 dated October 21, 2005 is being updated and reprinted to ensure that the Noridian Administrative

More information

Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies

Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies Richard Wender, MD Session code: www.worldcancercongress.org A Five Step Framework to Guide Screening

More information

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years

More information

Office of Population Health Genomics

Office of Population Health Genomics Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation

More information

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal

More information

Breast cancer in the family

Breast cancer in the family Birmingham Women's NHS Foundation Trust Breast cancer in the family Information for women with a slightly increased risk of breast cancer This is a no smoking hospital Breast cancer in the family what

More information

Nicole Kounalakis, MD

Nicole Kounalakis, MD Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations

More information

Guide to Understanding Breast Cancer

Guide to Understanding Breast Cancer An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who

More information

ductal carcinoma in situ (DCIS)

ductal carcinoma in situ (DCIS) Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre

More information

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding

More information

Breast Cancer in the Family

Breast Cancer in the Family Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Breast Cancer in the Family Information for women with a moderately increased risk of breast cancer Breast cancer in the family

More information

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.

More information

MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW

MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW Middle East Journal of Family Medicine, 2004; Vol. 6 (6) MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW Elias A Sarru', MD, MS, AAFP, ABFP Family Physician, Al Hasa Primary Care Services Division Faysal

More information

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014 General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

Ductal carcinoma in situ (DCIS)

Ductal carcinoma in situ (DCIS) DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made

More information

Common Breast Complaints:

Common Breast Complaints: : Palpable mass Abnormal mammogram with normal physical exam Vague thickening or nodularity Nipple Discharge Breast pain Breast infection or inflammation The physician s goal is to determine whether the

More information

Mammograms & Breast Health. An Information Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention

Mammograms & Breast Health. An Information Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Mammograms & Breast Health An Information Guide for Women This booklet was developed by the Centers for Disease Control

More information

Breast Cancer Awareness Month

Breast Cancer Awareness Month Aon Kenya Insurance Brokers Ltd Aon Hewitt Healthcare Division Breast Cancer Awareness Month Issue 12 October 2015 In this Issue 2 Cancer Statistics in Kenya 3 What is Breast Cancer? 4 Symptoms of Breast

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

The Greater Atlanta Affiliate 2004-2005 Grant Recipients

The Greater Atlanta Affiliate 2004-2005 Grant Recipients The Greater Atlanta Affiliate 2004-2005 Grant Recipients Atlanta Lesbian Cancer Initiative Treatment, Education, Support & Screening: This award supports psychosocial, informational, and physical support

More information

Understanding your pathology report

Understanding your pathology report Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What

More information

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women

More information

A Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer

A Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer A Guide to Breast Imaging: The Latest Technology for Screening and Detecting Breast Cancer Sally Herschorn, MD Associate Professor of Radiology University of Vermont College of Medicine Medical Director

More information

Breast cancer affects one in eight Australian women. It is the most common cancer for Victorian women, with almost 3,700 diagnoses in 2012.

Breast cancer affects one in eight Australian women. It is the most common cancer for Victorian women, with almost 3,700 diagnoses in 2012. Breast cancer Summary Breast cancer affects one in nine Australian women. It is important for all women to get to know the normal look and feel of their breasts. Although most breast changes aren t caused

More information

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor. Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast

More information

Breast Cancer Toolkit. Marion DePuit, MSN, Faith Community Nurse. Leslie Brown, BA, Community Advocate 9/2014. Understanding Breast Cancer

Breast Cancer Toolkit. Marion DePuit, MSN, Faith Community Nurse. Leslie Brown, BA, Community Advocate 9/2014. Understanding Breast Cancer GENERAL: Breast Cancer Toolkit Marion DePuit, MSN, Faith Community Nurse Leslie Brown, BA, Community Advocate 9/2014 Understanding Breast Cancer (Adapted from the American Cancer Society and Breast Cancer.org)

More information

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof

More information

www.downstatesurgery.org

www.downstatesurgery.org Male Breast Cancer Rabih Nemr MD Kings County Hospital August 2008 ACGME Core Competencies 1 Patient t Care Medical Knowledge 2 g 3 4 Practice Based Learning/Improvement Interpersonal Communication Skills

More information

GUIDELINES ADJUVANT SYSTEMIC BREAST CANCER

GUIDELINES ADJUVANT SYSTEMIC BREAST CANCER GUIDELINES ADJUVANT SYSTEMIC BREAST CANCER Author: Dr Susan O Reilly On behalf of the Breast CNG Written: December 2008 Agreed at CNG: June 2009 & June 2010 Review due: June 2011 Guidelines Adjuvant Systemic

More information

Prostate Cancer Screening in Taiwan: a must

Prostate Cancer Screening in Taiwan: a must Prostate Cancer Screening in Taiwan: a must 吳 俊 德 基 隆 長 庚 醫 院 台 灣 醫 學 會 105 th What is the PSA test? The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally

More information

Abnormal Uterine Bleeding FAQ Sheet

Abnormal Uterine Bleeding FAQ Sheet Abnormal Uterine Bleeding FAQ Sheet What is abnormal uterine bleeding? Under normal circumstances, a woman's uterus sheds a limited amount of blood during each menstrual period. Bleeding that occurs between

More information

Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE

Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the

More information

The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK

The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.

More information

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006 Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd

More information

Feeling Your Way To Healthy Breast. Lisa Barnes, BSN, RN Ruth Fay,B.A.,M.B.A.,RN Mary Grady, BSN, RN Margaret Richmond, MA, RN

Feeling Your Way To Healthy Breast. Lisa Barnes, BSN, RN Ruth Fay,B.A.,M.B.A.,RN Mary Grady, BSN, RN Margaret Richmond, MA, RN Feeling Your Way To Healthy Breast Lisa Barnes, BSN, RN Ruth Fay,B.A.,M.B.A.,RN Mary Grady, BSN, RN Margaret Richmond, MA, RN WHAT ARE MY BREASTS MADE OF? A breast is made of three main parts: glands,

More information

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet BRCA Genes and Inherited Breast and Ovarian Cancer Patient information leaflet This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could

More information

Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation

Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs Michael Alvarado, MD Associate Professor of Surgery University of California San Francisco Case Study 59 yo woman with new palpable

More information

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast

More information

Adjuvant Therapy for Breast Cancer: Questions and Answers

Adjuvant Therapy for Breast Cancer: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast

More information

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES Since breast cancer is not a systemic disease from inception, when the imagers find in situ and 1-14 mm invasive breast cancer, it is the surgeon, specialized in the treatment of breast diseases, who should

More information

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Current Status and Perspectives of Radiation Therapy for Breast Cancer Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic

More information

What You Need to Know Before Treatment About: Breast Cancer

What You Need to Know Before Treatment About: Breast Cancer What You Need to Know Before Treatment About: Breast Cancer Publication MDCH-1234 Revised: September 2008 Authority: Public Act 368 of 1978, as amended by Public Act 195 of 1986 and Public Act 15 of 1989.

More information

Pain Quick Reference for ICD 10 CM

Pain Quick Reference for ICD 10 CM Pain Quick Reference for ICD 10 CM Coding of acute or chronic pain in ICD 10 CM are located under category G89, Pain, not elsewhere classified. The subcategories are broken down by type, temporal parameter,

More information

What is DCIS? Contents. The breasts

What is DCIS? Contents. The breasts This information is an extract from the booklet Understanding ductal carinoma in situ (DCIS). You may find the full booklet helpful. We can send you a free copy see page 6. Contents The breasts What is

More information

Woman breast. and the. breast

Woman breast. and the. breast Woman breast and the breast Preface I am convinced that in the vast field of the battle against various forms of cancer, informing the community is one of most effective practice. As a result all the

More information

Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue

Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue page 1 Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue Q: What is breast cancer, and what type do I have? A: Cancer is a disease in which cells become abnormal and form more cells in

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

Official reprint from UpToDate www.uptodate.com 2013 UpToDate

Official reprint from UpToDate www.uptodate.com 2013 UpToDate Official reprint from UpToDate www.uptodate.com 2013 UpToDate Patient information: Breast cancer screening (The Basics) Written by the doctors and editors at UpToDate What is breast cancer screening? Breast

More information

CMS Limitations Guide Mammograms and Bone Density Radiology Services

CMS Limitations Guide Mammograms and Bone Density Radiology Services CMS Limitations Guide Mammograms and Bone Density Radiology Services Starting July 1, 2008, CMS has placed numerous medical necessity limits on tests and procedures. This reference guide provides you with

More information

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH 9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing

More information

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public

More information

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection

More information

BREAST CANCER PATHOLOGY

BREAST CANCER PATHOLOGY BREAST CANCER PATHOLOGY FACT SHEET Version 4, Aug 2013 This fact sheet was produced by Breast Cancer Network Australia with input from The Royal College of Pathologists of Australasia I m a nurse and know

More information

Cervical Cancer The Importance of Cervical Screening and Vaccination

Cervical Cancer The Importance of Cervical Screening and Vaccination Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this

More information

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 General Data Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 The vast majority of the patients in this study were diagnosed

More information

APGO Clinical Skills Curriculum. The Breast Exam

APGO Clinical Skills Curriculum. The Breast Exam APGO Clinical Skills Curriculum The Breast Exam Association of Professors of Gynecology and Obstetrics (APGO) Undergraduate Medical Education Committee 2008 The Breast Exam Table of Contents Intended Learning

More information

Surgical guidelines for the management of breast cancer

Surgical guidelines for the management of breast cancer Available online at www.sciencedirect.com EJSO xx (2009) S1eS22 www.ejso.com Guidelines Surgical guidelines for the management of breast cancer Contents Association of Breast Surgery at BASO 2009 Introduction...

More information

THYROID CANCER. I. Introduction

THYROID CANCER. I. Introduction THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

Modifiers 25 and 59. Modifier 25

Modifiers 25 and 59. Modifier 25 Modifiers 25 and 59 This article discusses the appropriate use of modifier 25, Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure

More information

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11

More information

Follow-Up Care for Breast Cancer

Follow-Up Care for Breast Cancer A Patient s Guide Follow-Up Care for Breast Cancer Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is a nonprofit organization which represents

More information

Illness Prevention and Health Promotion Services Provided by Nurse Practitioners: Predicting Potential Consumers

Illness Prevention and Health Promotion Services Provided by Nurse Practitioners: Predicting Potential Consumers Illness Prevention and Health Promotion Services Provided by Nurse Practitioners: Predicting Potential Consumers NOLA J. PENDER, PHD, AND ALBERT R. PENDER, PHD Abstract: A cross-sectional survey of 388

More information

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David

More information

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500

More information

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC). INTRODUCTION This book has been prepared for people with bowel cancer, their families and friends. The first section is for people with bowel cancer, and is intended to help you understand what bowel cancer

More information

Having a Breast Biopsy. A Guide for Women and Their Families

Having a Breast Biopsy. A Guide for Women and Their Families Having a Breast Biopsy A Guide for Women and Their Families Fast Facts n n Most women who have a breast biopsy do not have breast cancer. About 4 out of every 5 breast biopsies are negative for cancer.

More information

Breast Cancer Understanding your diagnosis

Breast Cancer Understanding your diagnosis Breast Cancer Understanding your diagnosis Let s Make Cancer History 1 888 939-3333 cancer.ca Breast Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and

More information

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine

More information

Frequently Asked Questions About Ovarian Cancer

Frequently Asked Questions About Ovarian Cancer Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues

More information

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj. PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition weiss@umdnj.edu September 23, 2010 Screening: 3 tests for PCa A good screening

More information

BreastScreen and You. Information about mammographic screening

BreastScreen and You. Information about mammographic screening BreastScreen and You Information about mammographic screening This information is about screening for breast cancer. It aims to help you choose whether or not you take part in the BreastScreen Australia

More information

Male breast cancer - Wikipedia, the free encyclopedia

Male breast cancer - Wikipedia, the free encyclopedia pagina 1 van 5 Male breast cancer From Wikipedia, the free encyclopedia Male breast cancer is a relatively rare cancer in men that originates from the breast. As it presents a similar pathology as female

More information

Male Breast Cancer. Abstract

Male Breast Cancer. Abstract Male Breast Cancer N. Kayani,M. N. Khan,Y. Bhurgri,S. Gill,M. I. Nasir ( The Aga Khan University Medical Center. Karachi. ) T. Siddiqui ( Departments of Pathology and Medicine, The Aga Khan University,

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center Hereditary Multifocal Breast Cancer Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center CASE STUDY 30 year old Ashkenazi Jewish woman Nulliparous Felt

More information

Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required]

Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required] Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required] Medical Policy: MP-SU-01-11 Original Effective Date: February 24, 2011 Reviewed: Revised: This policy applies

More information

A Checklist for Patients with Breast Cancer

A Checklist for Patients with Breast Cancer A Checklist for Patients with Breast Cancer Questions to Ask the Doctor 1 and Quick Help Resources 1 Adapted from: American Cancer Society. Detailed Guide: Breast Cancer - What Should You Ask Your Doctor

More information

Basic Study Designs in Analytical Epidemiology For Observational Studies

Basic Study Designs in Analytical Epidemiology For Observational Studies Basic Study Designs in Analytical Epidemiology For Observational Studies Cohort Case Control Hybrid design (case-cohort, nested case control) Cross-Sectional Ecologic OBSERVATIONAL STUDIES (Non-Experimental)

More information

SUBJECT: MANAGEMENT OF BREAST EFFECTIVE DATE: 12/16/99 IMPLANTS REVISED DATE:

SUBJECT: MANAGEMENT OF BREAST EFFECTIVE DATE: 12/16/99 IMPLANTS REVISED DATE: MEDICAL POLICY SUBJECT: MANAGEMENT OF BREAST PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

Prostate Cancer. Treatments as unique as you are

Prostate Cancer. Treatments as unique as you are Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential

More information

Screening for Prostate Cancer

Screening for Prostate Cancer Screening for Prostate Cancer It is now clear that screening for Prostate Cancer discovers the disease at an earlier and more curable stage. It is not yet clear whether this translates into reduced mortality

More information

The best treatment Your guide to breast cancer treatment in England and Wales

The best treatment Your guide to breast cancer treatment in England and Wales The best treatment Your guide to breast cancer treatment in England and Wales If you are looking for information on the treatment of secondary breast cancer (also known as advanced or metastatic breast

More information

Cancer of the Cervix

Cancer of the Cervix Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,

More information

Breast Ultrasound: Benign vs. Malignant Lesions

Breast Ultrasound: Benign vs. Malignant Lesions October 25-November 19, 2004 Breast Ultrasound: Benign vs. Malignant Lesions Jill Steinkeler,, Tufts University School of Medicine IV Breast Anatomy Case Presentation-Patient 1 62 year old woman with a

More information

Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation

Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation Yan Xing, MD, PhD, Ryaz B. Chagpar, MD, MS, Y Nancy You MD, MHSc, Yi Ju Chiang, MSPH, Barry W. Feig, MD, George

More information

Chapter 2 History of MD Anderson s Tumor Registry

Chapter 2 History of MD Anderson s Tumor Registry Chapter 2 History of MD Anderson s Tumor Registry Sarah H. Taylor The Tumor Registry Department at The University of Texas MD Anderson Cancer Center is responsible for a database that contains demographic

More information

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including

More information